Interestingly, the non-adhesion-blocking antibody, ASC-3, demonstrated anti-tumor effects in vitro in our prior studies [15], supporting the conclusion that the tumorigenic properties of β4 can be targeted independently of the adhesive properties to laminins. This evidence concerns the gene LAMB2 and neoplasm.